Skip to main content

Table 4 Cognitive function after inhaled THC based on Short-Blessed Test (SBT)

From: Smokeless consumption of medical cannabis pharmacokinetics, safety and feasibility of the CannaHALER© a phase 1a study

 Group I
10 ± 0.1 mg		Group II
15 ± 0.1 mg		Group III
20 ± 0.1 mg		Group IV
25 ± 0.1 mg
SBT 0 min0.66 ± 0.9402 ± 1.632 ± 2.82
SBT 30 min2.33 ± 3.291.33 ± 1.880.66 ± 0.940
SBT 120 min2.66 ± 0.473 ± 0.810.66 ± 0.940
  1. The SBT is a weighted six-item instrument that evaluates cognitive impairment using surrogates for orientation, registration, and attention. Patients in the THC dosage groups showed no change in SBT levels during the time frame of the study
  2. SBT Short Blessed test score
Back to article page

Journal of Cannabis Research

ISSN: 2522-5782

\